Related Experiment Video
Updated: Jul 22, 2026
09:46
Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
20.4K
Chemically Defined, Efficient Megakaryocyte Production from Human Pluripotent Stem Cells.
Jae Eun Kim1, Yeonmi Lee1,2, Yonghee Kim1
1CHA R&D Institute, CHA Bundang Medical Center, Seongnam 13488, Republic of Korea.
Cells
|November 26, 2025
Summary
Generating human pluripotent stem cell-derived megakaryocytes (hPSC-MKs) is crucial for research. A new protocol uses Butyzamide and M-CSF in 3D culture for efficient, high-quality MK production without TPO.
Area of Science:
- Biotechnology
- Stem Cell Biology
- Hematology
Background:
- Platelet shortages hinder medical research and therapies.
- Native megakaryocytes (MKs) are difficult to obtain in sufficient quantities.
- Pluripotent stem cell-derived MKs (PSC-MKs) offer a promising alternative for research and platelet production.
Purpose of the Study:
- To develop a chemically defined, feeder-free protocol for generating MKs from human pluripotent stem cells (hPSCs).
- To investigate the efficacy of Butyzamide as a thrombopoietin (TPO) replacement and the role of M-CSF and 3D culture in MK differentiation.
Main Methods:
- Utilized human pluripotent stem cells (hPSCs) in a chemically defined, feeder-free system.
- Employed a combination of Butyzamide (MPL agonist), M-CSF, and 3D suspension culture for MK differentiation.
- Analyzed MK development using flow cytometry (CD41/CD42b), microscopy, mitochondrial respiration assays, and single-cell RNA sequencing.
Main Results:
- Achieved high efficiency and reproducibility in generating MKs from hPSCs.
- Butyzamide promoted polyploidization, while M-CSF enhanced nuclear lobulation and 4N MK formation.
- 3D culture increased MK yield, cell size, and facilitated substrate detachment, confirming mature MK characteristics.
Conclusions:
- The developed protocol provides a reliable and scalable platform for producing MKs from hPSCs.
- This method enables consistent supply of MKs for disease modeling, mechanistic studies, and ex vivo platelet generation.
- Advances in stem cell technology offer new avenues for therapeutic development in hematology.
Related Concept Videos
01:14Introduction to Nuclear Reprogramming
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
01:24Methods of Nuclear Reprogramming
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.
01:13Cell Diversity
The concept of a cell started with microscopic observations of dead cork tissue by Robert Hooke in 1665. Hooke coined the term "cell" based on the resemblance of the small subdivisions in the cork to the rooms that monks inhabited, called cells. About ten years later, Antonie van Leeuwenhoek became the first person to observe the living and moving cells under a microscope. In the century that followed, the theory that cells represented the basic unit of life developed.
Multicellular organisms...
Multicellular organisms...